🔎 Trials Near Me

Home › Alzheimer's Disease › Florida › Tampa

Alzheimer's Disease clinical trials in Tampa, FL

17 studies for Alzheimer's Disease are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

RecruitingPhase 2
  • Clinical Site, Tampa
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

RecruitingPhase 2
  • University of South Florida, Tampa
Ages 55 and older · All sexes · Updated Sep 29, 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

RecruitingPhase 3
  • IPTB Clinical Research, Tampa
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

RecruitingPhase 3
  • Guardian Angel Research, Tampa
  • Interventional Psychiatry of Tampa Bay, Tampa
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

RecruitingPhase 2
  • Axiom Brain Health LLC, Tampa
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

Microbiome in Aging of Gut and Brain

RecruitingObservational studyHealthy volunteers welcome
  • Department of Neurosurgery and Brain and Spine and Faculty of USF Center for Microbiome Re-search, Microbiomes Institute, Tampa
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07799402

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

RecruitingPhase 3
  • Axiom Brain Health LLC, Tampa
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

RecruitingPhase 3
  • USF Health Byrd Alzheimer's Institute, Tampa
Ages 60 to 85 · All sexes · Updated Sep 17, 2026 · NCT06976203

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

RecruitingPhase 3
  • IPTB Clinical Research, Tampa
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

RecruitingPhase 2
  • Local Institution - 0001, Tampa
  • Local Institution - 0080, Tampa
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

RecruitingPhase 2
  • Axiom Brain Health ( Site 1029), Tampa
  • K2 Medical Research ( Site 1020), Tampa
Ages 50 to 85 · All sexes · Updated Aug 26, 2026 · NCT07033494

AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

RecruitingPhase 1
  • University of South Florida, Tampa
Ages 65 to 80 · All sexes · Updated Aug 21, 2026 · NCT07158905

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

RecruitingPhase 3
  • Care Access - Tampa, Tampa
  • K2 Medical Research - Tampa, Tampa
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

RecruitingPhase 1Healthy volunteers welcome
  • K2 Medical Research - Tampa, Tampa
Ages 45 to 85 · All sexes · Updated Jun 4, 2026 · NCT06657768

Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)

RecruitingHealthy volunteers welcome
  • University of South Florida, Tampa
  • University of South Florida, Tampa
Ages 21 and older · All sexes · Updated Apr 29, 2026 · NCT06722352

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Recruiting
  • Tampa General Hospital, Tampa
Ages 50 to 85 · All sexes · Updated Jan 9, 2026 · NCT03671889

About Alzheimer's Disease

Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.

More about Alzheimer's Disease on MedlinePlus

Alzheimer's Disease trials in other cities

Other studies in Tampa

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.